Last update 08 May 2025

Methoxyphenamine Hydrochloride/Narcosine/Aminophylline/Chlorphenamine Maleate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
阿斯美
Target
H1 receptor x cGMP-PDE x β2-adrenergic receptor
Action
antagonists, inhibitors, agonists
Mechanism
H1 receptor antagonists(Histamine H1 receptor antagonists), cGMP-PDE inhibitors(3',5'-cyclic phosphodiesterase inhibitors), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesRespiratory Diseases
Active Indication
AsthmaBronchitis
Inactive Indication-
Originator Organization
Daiichi Sankyo Co., Ltd.Daiichi Sankyo Co., Ltd.
Active Organization
Daiichi Sankyo Pharmaceutical (Shanghai) Co. Ltd.Daiichi Sankyo Pharmaceutical (Shanghai) Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
China (01 Jan 2003),
AsthmaBronchitis
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC9H16N6O2
InChIKeyLHRHXWBJUQKYEL-UHFFFAOYSA-N
CAS Registry317-34-0
View All Structures (4)

Related

100 Clinical Results associated with Methoxyphenamine Hydrochloride/Narcosine/Aminophylline/Chlorphenamine Maleate
Login to view more data
100 Translational Medicine associated with Methoxyphenamine Hydrochloride/Narcosine/Aminophylline/Chlorphenamine Maleate
Login to view more data
100 Patents (Medical) associated with Methoxyphenamine Hydrochloride/Narcosine/Aminophylline/Chlorphenamine Maleate
Login to view more data
100 Deals associated with Methoxyphenamine Hydrochloride/Narcosine/Aminophylline/Chlorphenamine Maleate
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Asthma
China
Daiichi Sankyo Pharmaceutical (Shanghai) Co. Ltd.Daiichi Sankyo Pharmaceutical (Shanghai) Co. Ltd.
01 Jan 2003
Bronchitis
China
Daiichi Sankyo Pharmaceutical (Shanghai) Co. Ltd.Daiichi Sankyo Pharmaceutical (Shanghai) Co. Ltd.
01 Jan 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free